The role of TRAIL death receptors in the treatment of hematological malignancies.
about
IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expressionThe necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells.BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomasRegulation of autophagy in hematological malignancies: role of reactive oxygen species.Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5.Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation.Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses.B cell receptor triggering sensitizes human B cells to TRAIL-induced apoptosis.Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-kappaB.Synergistic antitumor effect of TRAIL and adriamycin on the human breast cancer cell line MCF-7.Targeting metabolism and autophagy in the context of haematologic malignanciesDeath receptor 5 and neuroproliferation.Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
P2860
Q24642376-AB3A40B8-0829-42E5-8E20-E3AA50FE6B3DQ33442825-7A72E943-F052-4840-ABD2-0130878713C3Q36809469-6D8C7287-5B75-49D7-81B0-1F1A01870C4BQ37900322-CC139BE6-A7F9-4578-9C0C-8C99A58099E4Q38827688-24D319FF-502A-4968-8253-A19AA9A429EDQ39256130-4D5B1875-83C1-467C-9B96-AA7075D54837Q39519488-663155E0-5EA3-42D7-8B4D-D3AF582F85C9Q39667395-21037CD0-39F2-495F-9449-2D620322D67DQ39730593-57421329-67EC-4929-9672-83435B260244Q39801855-AE718AD3-9DDA-4577-B6A1-128871C281C9Q42241012-35F956DD-C1F6-440C-9512-52159729B4CCQ48884086-B4DD779A-84E3-45FF-9393-B0A022658998Q54407620-09EBAA79-2740-45A6-A250-FF8AB091D188
P2860
The role of TRAIL death receptors in the treatment of hematological malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of TRAIL death receptors in the treatment of hematological malignancies.
@en
The role of TRAIL death receptors in the treatment of hematological malignancies.
@nl
type
label
The role of TRAIL death receptors in the treatment of hematological malignancies.
@en
The role of TRAIL death receptors in the treatment of hematological malignancies.
@nl
prefLabel
The role of TRAIL death receptors in the treatment of hematological malignancies.
@en
The role of TRAIL death receptors in the treatment of hematological malignancies.
@nl
P2093
P2860
P1433
P1476
The role of TRAIL death receptors in the treatment of hematological malignancies.
@en
P2093
Elizabeth S Henson
James B Johnston
Spencer B Gibson
P2860
P356
10.1080/10428190701713655
P577
2008-01-01T00:00:00Z